CE-EUS在胰腺疾病诊治中的应用㈡自身免疫性胰腺炎与胰腺癌的鉴别H.Imazu,etal.ScandJGastroenterol,2012CE-EUS在胰腺疾病诊治中的应用㈡自身免疫性胰腺炎与胰腺癌（PDAC）的鉴别H.Imazu,etal.ScandJGastroenterol,2012CE-EUS在胰腺疾病诊治中的应用㈡自身免疫性胰腺炎与胰腺癌（PDAC）的鉴别H.Imazu,etal.ScandJGastroenterol,2012CE-EUS在胰腺疾病诊治中的应用㈡自身免疫性胰腺炎与胰腺癌（PDAC）的鉴别Results：OnthebasisoftheROCcurvedata,theoptimalMIGcutoffvaluetodifferentiateAIPfrompancreaticcarcinomawas12.5.Thesensitivityandspecificitywere100%(95%CI81.47–100)and100%(95%CI63.06–100),respectively,andtheareaunderthecurvewas1.0H.Imazu,etal.ScandJGastroenterol,2012
